Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which of the following drugs does not produce active metabolites?

Lisinopril. The core concept tested here is the difference between **active drugs** and **prodrugs**. A prodrug is pharmacologically inactive and must be metabolized (usually by the liver) into an active metabolite to exert its effect [2]. **1. Why Lisinopril is the correct answer:** Most ACE inhibitors are prodrugs (e.g., Enalapril to Enalaprilat) to improve oral bioavailability. However, **Lisinopril** and **Captopril** are the two major exceptions. Lisinopril is an active drug; it is not metabolized by the liver and is excreted unchanged in the urine. Therefore, it does not produce active metabolites [1]. **2. Analysis of Incorrect Options:** * **Enalapril (Option A):** It is a prodrug converted by hepatic esterases into its active form, **Enalaprilat** [1]. * **Prednisone (Option C):** It is a corticosteroid prodrug that must be converted in the liver by the enzyme 11β-HSD to its active form, **Prednisolone** [3]. * **Sulfasalazine (Option D):** It is broken down by colonic bacteria into **Sulfapyridine** and **5-aminosalicylic acid (5-ASA)**; the latter is the active moiety used in treating Ulcerative Colitis [4]. **High-Yield Clinical Pearls for NEET-PG:** * **ACE Inhibitor Exceptions:** Remember the mnemonic **"CL"** (Captopril and Lisinopril) as the ACE inhibitors that are *not* prodrugs. * **Lisinopril** is preferred in patients with liver disease because it does not require hepatic activation. * **Active Drugs vs. Prodrugs:** Most drugs are active as administered. Common prodrugs to remember for exams include Levodopa (to Dopamine), Cyclophosphamide (to Phosphoramide mustard), and Clopidogrel.

Q: Excretion of barbiturates in the urine can be increased by which of the following interventions?

Urinary alkalinization. **Explanation:**The excretion of barbiturates (specifically Phenobarbital) is increased by **urinary alkalinization** through the principle of **ion trapping**.**1. Why Urinary Alkalinization is Correct:**Barbiturates are **weakly acidic** drugs. According to the Henderson-Hasselbalch principle, acidic drugs remain non-ionized in acidic environments and become **ionized (charged)** in alkaline environments. By administering Sodium Bicarbonate ($NaHCO_3$) to alkalinize the urine, the barbiturate molecules become ionized. Since ionized drugs are lipid-insoluble, they cannot be reabsorbed across the renal tubular epithelium back into the blood and are instead "trapped" in the tubular lumen and excreted [1].**2. Why Other Options are Incorrect:** * **Diuretics (A):** While forced diuresis increases urine volume, it is significantly less effective than altering pH for weak acids and is no longer the primary recommendation due to the risk of pulmonary edema. * **Urinary Acidification (C):** This would keep the acidic barbiturate in a non-ionized, lipid-soluble state, promoting its reabsorption into the systemic circulation and worsening toxicity. (Acidification is used for weak bases like Amphetamines). * **Hemodialysis (D):** While effective for severe poisoning, it is an invasive procedure. Urinary alkalinization is the first-line pharmacological intervention for enhancing renal clearance.**Clinical Pearls for NEET-PG:** * **Mnemonic:** **A**cidic drugs are excreted in **A**lkaline urine (e.g., Barbiturates, Salicylates, Methotrexate). * **Agent used:** Intravenous **Sodium Bicarbonate** is the drug of choice for urinary alkalinization. * **Target pH:** The goal is to maintain a urinary pH between **7.5 and 8.5**. * **Note:** Only long-acting barbiturates like **Phenobarbital** are significantly excreted by the kidneys; short-acting ones are primarily metabolized by the liver.

Q: ED50 is used for determining which of the following?

Potency. **Explanation:** **1. Why Potency is Correct:** Potency refers to the amount of drug (dose) required to produce an effect of a given intensity. It is measured by the **ED50 (Median Effective Dose)**, which is the dose required to produce a specified therapeutic effect in 50% of the population (in quantal dose-response curves) or the dose that produces 50% of the maximal response (in graded curves). A drug with a lower ED50 is considered more potent because a smaller dose is needed to achieve the same effect. **2. Why Other Options are Incorrect:** * **B. Efficacy:** This refers to the maximum effect ($E_{max}$) a drug can produce, regardless of dose. It is determined by the height of the dose-response curve, not the ED50. * **C. Safety:** Safety is determined by the **Therapeutic Index (TI)**, which is the ratio of the median lethal dose to the median effective dose ($TI = LD_{50} / ED_{50}$). * **D. Toxicity:** This is measured by the **TD50 (Median Toxic Dose)**, which is the dose that produces a specific toxic effect in 50% of the population. **Clinical Pearls for NEET-PG:** * **Potency vs. Efficacy:** Efficacy is clinically more important than potency. For example, Furosemide is more efficacious than Thiazides (it can remove more fluid), even if a Thiazide might be more potent (requiring fewer milligrams). * **Drug Comparison:** On a dose-response graph, if Curve A is to the **left** of Curve B, Drug A is more **potent**. If Curve A is **higher** than Curve B, Drug A has higher **efficacy**. * **Therapeutic Window:** The range between the minimum effective therapeutic concentration and the minimum toxic concentration.

Q: Which of the following is an example of learned tolerance?

Walking a straight line when intoxicated. **Explanation:** **Learned Tolerance** (also known as behavioral tolerance) refers to a reduction in the effects of a drug that results from compensatory mechanisms learned by the individual through experience. It occurs when a person performs a task repeatedly while under the influence of a drug, eventually learning to function effectively despite the impairment. **Why Option C is Correct:** Walking a straight line while intoxicated is the classic example of learned tolerance. An individual who frequently consumes alcohol learns to consciously coordinate their motor movements and utilize visual cues to compensate for the cerebellar ataxia and vestibular impairment caused by ethanol. This is a behavioral adaptation rather than a change in drug metabolism or receptor sensitivity. **Analysis of Incorrect Options:** * **Options A, B, and D** represent **behavioral modifications** or safety strategies. Avoiding alcohol when unsteady, eating food to slow absorption (pharmacokinetic intervention), or choosing not to drive are conscious decisions to mitigate risk, but they do not involve the physiological or psychological "learning" to overcome a drug-induced deficit while the drug is active in the system. **High-Yield NEET-PG Pearls:** 1. **Pharmacodynamic Tolerance:** Occurs due to adaptive changes in the biological system (e.g., down-regulation of receptors like GABA receptors in chronic benzodiazepine use). 2. **Pharmacokinetic (Metabolic) Tolerance:** Occurs when the drug induces its own metabolism (e.g., Carbamazepine or Phenobarbitone inducing Cytochrome P450 enzymes). 3. **Tachyphylaxis:** A form of acute tolerance where drug effects diminish rapidly after only a few doses (e.g., Ephedrine, Tyramine, Nitroglycerin). 4. **Reverse Tolerance (Sensitization):** An increase in response to the same dose of a drug with repeated use (e.g., Cocaine-induced seizures).

Q: Which of the following statements regarding plasma protein binding is NOT true?

Nephrotic syndrome does not affect plasma protein binding.. ### Explanation **1. Why Option C is the Correct Answer (The "NOT True" Statement):** Plasma protein binding is significantly altered in **Nephrotic Syndrome**. This condition is characterized by massive proteinuria, leading to **hypoalbuminemia**. Since many drugs (especially acidic ones) rely on albumin for transport, a decrease in albumin levels results in a higher **free fraction** of the drug. This can lead to increased pharmacological effects or potential toxicity even at standard doses. Therefore, saying it "does not affect" binding is medically incorrect. **2. Analysis of Incorrect Options:** * **Option A:** This is a fundamental principle. Only the **free (unbound) fraction** can cross biological membranes, interact with receptors, and undergo metabolism/excretion. The bound fraction acts as a reservoir. * **Option B:** Generally, **acidic drugs** (e.g., NSAIDs, Warfarin, Phenytoin) bind to **Albumin**, while **basic drugs** (e.g., Lidocaine, Propranolol) bind to **Alpha-1-acid glycoprotein (AAG)**. * **Option D:** Prazosin is a basic drug. Basic drugs predominantly bind to **Alpha-1-acid glycoprotein**, making this statement true. **3. High-Yield Clinical Pearls for NEET-PG:** * **Albumin vs. AAG:** Albumin levels decrease in liver disease and nephrotic syndrome. AAG is an "acute-phase reactant"; its levels **increase** during inflammation, surgery, or myocardial infarction, potentially decreasing the free fraction of basic drugs. * **Displacement Interactions:** Highly protein-bound drugs (e.g., Warfarin) can be displaced by other drugs (e.g., Sulfonamides), leading to a sudden spike in the free fraction and toxicity. * **Volume of Distribution (Vd):** Drugs with high plasma protein binding typically have a **low Vd**, as they are sequestered within the vascular compartment.

Q: What percentage of a drug remains in the body after 3 half-lives?

12.50%. **Explanation:** The concept tested here is the **elimination kinetics** of a drug, specifically focusing on the **half-life ($t_{1/2}$)**. The half-life is the time required for the plasma concentration of a drug to be reduced by 50%. **Why 12.50% is Correct:** In first-order kinetics (followed by most drugs), a constant fraction of the drug is eliminated per unit of time. The percentage of the drug remaining follows a predictable decay pattern: * **0 Half-life:** 100% remains. * **1 Half-life:** 50% remains (50% eliminated). * **2 Half-lives:** 25% remains (50% of 50%; 75% eliminated). * **3 Half-lives:** **12.50% remains** (50% of 25%; 87.5% eliminated). **Analysis of Incorrect Options:** * **B (75%):** This represents the amount **eliminated** after 2 half-lives, not the amount remaining after 3. * **C (87.50%):** This is the total percentage of the drug **eliminated/cleared** from the body after 3 half-lives ($100 - 12.5 = 87.5$). * **D (94%):** This is the approximate percentage of the drug **eliminated** after 4 half-lives ($100 - 6.25 = 93.75$). **NEET-PG High-Yield Pearls:** 1. **Steady State:** It takes approximately **4 to 5 half-lives** for a drug to reach steady-state concentration ($C_{ss}$) during constant-rate infusion. 2. **Complete Elimination:** For clinical purposes, a drug is considered "completely" eliminated from the body after **5 half-lives** (96.8% cleared). 3. **First-order vs. Zero-order:** In first-order kinetics, $t_{1/2}$ is constant. In zero-order kinetics (e.g., high-dose Aspirin, Phenytoin, Ethanol), a constant *amount* is eliminated, and $t_{1/2}$ is not constant. 4. **Formula:** Percentage remaining = $(1/2)^n \times 100$, where $n$ is the number of half-lives.

Q: Titration of drug dosage based on patient response is most effectively achieved with which of the following routes of administration?

Inhalation. **Explanation:** The core concept behind effective dose titration is the **rapidity of onset** and the **ability to terminate drug delivery** once the desired effect is achieved. **Why Inhalation is Correct:** The inhalation route offers a very large surface area (alveolar membrane) and high vascularity, leading to an almost instantaneous onset of action, similar to intravenous administration. More importantly, it allows for **breath-by-breath titration**. In clinical practice (e.g., volatile anesthetics like Sevoflurane), the clinician can increase or decrease the concentration of the drug in the inspired air and see an immediate change in the patient's physiological state. If an adverse effect occurs, stopping the inhalation leads to rapid elimination of the drug from the lungs. **Why Other Options are Incorrect:** * **Sublingual:** While it bypasses first-pass metabolism and has a quick onset (e.g., Nitroglycerin), once the tablet is dissolved, the dose cannot be "titrated" or withdrawn to fine-tune the response. * **Transdermal:** This route is designed for **slow, sustained release** (e.g., Fentanyl patches). It has a very long lag time to reach steady-state plasma levels, making it the least suitable for acute titration. * **Subcutaneous:** Absorption is relatively slow and depends on local blood flow. Once injected, the drug depot cannot be removed, preventing precise control over the immediate response. **High-Yield Clinical Pearls for NEET-PG:** * **Inhalation** is the fastest route for drugs to reach the brain (shorter path than IV). * **Bioavailability** of IV route is 100% by definition. * **First-pass metabolism** is bypassed by Sublingual, Transdermal, and Inhalation routes, but only partially bypassed by the Rectal route (approx. 50%).

Q: What does the clearance of a drug refer to?

All the above.. **Clearance (Cl)** is one of the most critical pharmacokinetic parameters in clinical practice. It represents the theoretical volume of plasma from which a drug is completely removed per unit of time (e.g., mL/min) [1]. 1. **Why Option A is correct:** Clearance is the quantitative measure of the body's efficiency in eliminating a drug. It is the sum of all elimination processes (Renal + Hepatic + Others). Mathematically, $Cl = ext{Rate of elimination} / ext{Plasma concentration}$ [2]. 2. **Why Option B is correct:** An organ cannot remove more drug than is delivered to it via blood. Therefore, the clearance of a drug by a specific organ (like the liver) can never exceed the blood flow to that organ ($Q$) [1]. For example, hepatic clearance cannot exceed hepatic blood flow (~1500 mL/min). 3. **Why Option C is correct:** This is a high-yield clinical concept. At steady state, the rate of drug administration equals the rate of elimination. The formula $Css = ext{Infusion rate} / Cl$ shows that clearance is the primary determinant of the **Steady-State Concentration ($C_{ss}$)** [1]. **Clinical Pearls for NEET-PG:** * **Maintenance Dose:** Clearance is the parameter used to calculate the maintenance dose ($MD = C_{ss} imes Cl$) [1]. * **Half-life ($t_{1/2}$):** Clearance is inversely proportional to half-life ($t_{1/2} = 0.693 imes Vd / Cl$). If clearance decreases (e.g., renal failure), the half-life increases. * **First-order Kinetics:** For most drugs, clearance remains constant regardless of the plasma concentration [2]. * **Zero-order Kinetics:** Clearance decreases as the plasma concentration increases (e.g., Phenytoin, Alcohol, Salicylates at high doses) [2].

Q: Arrange the following drugs according to increasing volume of distribution: 1. Haloperidol 2. Gentamicin 3. Heparin 4. Chloroquine?

3-2-1-4. **Explanation:** The **Volume of Distribution ($V_d$)** is a theoretical volume that relates the amount of drug in the body to its plasma concentration. It is determined by a drug's lipid solubility, ionization, and protein binding. 1. **Heparin ($V_d \approx 0.05$ L/kg):** Being a large, highly ionized molecule, it is confined almost entirely to the **plasma compartment**. It has the lowest $V_d$ among the options. 2. **Gentamicin ($V_d \approx 0.25$ L/kg):** As a polar/hydrophilic molecule (Aminoglycoside), it distributes into the **extracellular fluid (ECF)** but does not easily cross cell membranes. 3. **Haloperidol ($V_d \approx 15-20$ L/kg):** This is a lipophilic antipsychotic that crosses the blood-brain barrier and distributes into various tissues, resulting in a $V_d$ exceeding total body water. 4. **Chloroquine ($V_d \approx 13,000$ L/kg):** It is highly lipid-soluble and exhibits extensive **sequestration in tissues** (liver, spleen, lungs). It has one of the highest $V_d$ values in pharmacology. **Why Option B is correct:** The sequence **3 (Heparin) < 2 (Gentamicin) < 1 (Haloperidol) < 4 (Chloroquine)** correctly follows the progression from plasma-bound to ECF-bound to tissue-sequestered drugs. **Why other options are wrong:** * **Options A & C:** Incorrectly place Chloroquine before Haloperidol or Gentamicin before Heparin. * **Option D:** Incorrectly suggests Gentamicin has a lower $V_d$ than Heparin. **NEET-PG High-Yield Pearls:** * **Low $V_d$ ( 40L):** Drugs sequestered in tissues (e.g., Chloroquine, Digoxin, Amiodarone, TCAs). * **Clinical Significance:** Drugs with a high $V_d$ require a **Loading Dose** to achieve target plasma concentrations and are **not** effectively removed by hemodialysis during toxicity.

Question 1

Which of the following drugs does not produce active metabolites?

Accepted Answer

Lisinopril

Answer

Enalapril

Answer

Prednisone

Answer

Sulfasalazine

Question 2

Excretion of barbiturates in the urine can be increased by which of the following interventions?

Accepted Answer

Urinary alkalinization

Answer

Diuretics

Answer

Urinary acidification

Answer

Hemodialysis

Question 3

ED50 is used for determining which of the following?

Accepted Answer

Potency

Answer

Efficacy

Answer

Safety

Answer

Toxicity

Question 4

Which of the following is an example of learned tolerance?

Accepted Answer

Walking a straight line when intoxicated

Answer

Avoiding alcohol when feeling unsteady

Answer

Drinking alcohol only with food

Answer

Not driving when drunk

Question 5

Sodium thiopental is ultra-short acting due to –

Accepted Answer

Rapid redistribution

Answer

Rapid absorption

Answer

Rapid metabolism

Answer

Rapid excretion

Question 6

Which of the following statements regarding plasma protein binding is NOT true?

Accepted Answer

Nephrotic syndrome does not affect plasma protein binding.

Answer

The free fraction of a drug is considered pharmacologically active.

Answer

Acidic drugs typically bind to plasma albumin.

Answer

Prazosin is bound to alpha-1-acid glycoprotein.

Question 7

What percentage of a drug remains in the body after 3 half-lives?

Accepted Answer

12.50%

Answer

75%

Answer

87.50%

Answer

94%

Question 8

Titration of drug dosage based on patient response is most effectively achieved with which of the following routes of administration?

Accepted Answer

Inhalation

Answer

Sublingual

Answer

Transdermal

Answer

Subcutaneous

Question 9

What does the clearance of a drug refer to?

Accepted Answer

All the above.

Answer

The efficacy of elimination of a drug by an organ or the whole body.

Answer

It cannot be greater than the blood flow to an organ.

Answer

It determines the steady-state drug concentration.

Question 10

Arrange the following drugs according to increasing volume of distribution: 1. Haloperidol 2. Gentamicin 3. Heparin 4. Chloroquine?

Accepted Answer

3-2-1-4

Answer

3-2-4-1

Answer

2-3-4-1

Answer

2-1-3-4

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?